Byakangelicol
CAS No. 26091-79-2
Byakangelicol ( —— )
Catalog No. M18325 CAS No. 26091-79-2
Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 146 | In Stock |
|
10MG | 214 | In Stock |
|
25MG | 353 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameByakangelicol
-
NoteResearch use only, not for human use.
-
Brief DescriptionByakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions.
-
DescriptionByakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions. Byakangelicol can inhibit IL-1beta-induced PGE2 release in A549 cells; this inhibition may be mediated by suppression of COX-2 expression and the activity of COX-2 enzyme, thus it may have therapeutic potential as an anti-inflammatory drug on airway inflammation.
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorCOX-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26091-79-2
-
Formula Weight316.3
-
Molecular FormulaC17H16O6
-
Purity98%
-
Solubility——
-
SMILESCC1(C(O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Decursinol angelate
Decursinol angelate has anti-tumor, anti-inflammatory, anti-oxidant, and hepatoprotective activities, it inhibits VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
-
ISRIB
ISRIB is a potent and selective PERK inhibitor with IC50 of 5 nM.
-
BIX02189(c)
BIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM, also inhibits ERK5 catalytic activity with IC50 of 59 nM in cell-free assays.